What does CUSIP 30233M107 represent in this 13F holders report?

CUSIP 30233M107 is the security identifier for EYEG - EYEGATE PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held EYEG - EYEGATE PHARMACEUTICALS INC - COM in Q2 2016?

10 institutional investors reported EYEG - EYEGATE PHARMACEUTICALS INC - COM for Q2 2016. Use the holders table for investor-level position and value details.

EYEGATE PHARMACEUTICALS INC - COM (EYEG)

CUSIP: 30233M107

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / COM
Total 13F shares: 529,176
Share change: +440,281
Total reported value: $1,372,000
Price per share: $2.62
Number of holders: 10
Value change: +$1,134,798
Number of buys: 6
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 30233M107?
CUSIP 30233M107 identifies EYEG - EYEGATE PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP 30233M107:

Q3 2019 Q2 2019 Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017

Institutional Holders of EYEGATE PHARMACEUTICALS INC - COM (EYEG) as of Q2 2016

As of 30 Jun 2016, EYEGATE PHARMACEUTICALS INC - COM (EYEG) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 529,176 shares. The largest 10 holders included SABBY MANAGEMENT, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Fund Advisors, Vantage Investment Advisors, LLC, UBS Group AG, Acrospire Investment Management LLC, Tower Research Capital LLC (TRC), MORGAN STANLEY, and BlackRock Investment Management, LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.